Northern Trust’s Biolase, Inc. BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-300
Closed -$2.12K 4535
2023
Q2
$2.12K Hold
300
﹤0.01% 4528
2023
Q1
$8.43K Buy
300
+188
+168% +$5.28K ﹤0.01% 4539
2022
Q4
$7.3K Hold
112
﹤0.01% 4604
2022
Q3
$27K Hold
112
﹤0.01% 4491
2022
Q2
$51K Hold
112
﹤0.01% 4408
2022
Q1
$99K Hold
112
﹤0.01% 4339
2021
Q4
$110K Hold
112
﹤0.01% 4393
2021
Q3
$179K Buy
112
+2
+2% +$3.2K ﹤0.01% 4225
2021
Q2
$193K Hold
110
﹤0.01% 4176
2021
Q1
$233K Buy
110
+71
+182% +$150K ﹤0.01% 4060
2020
Q4
$41K Buy
39
+23
+144% +$24.2K ﹤0.01% 4256
2020
Q3
$11K Sell
16
-6
-27% -$4.13K ﹤0.01% 4257
2020
Q2
$26K Buy
22
+8
+57% +$9.46K ﹤0.01% 4135
2020
Q1
$14K Hold
14
﹤0.01% 4128
2019
Q4
$20K Hold
14
﹤0.01% 4158
2019
Q3
$34K Hold
14
﹤0.01% 4097
2019
Q2
$53K Hold
14
﹤0.01% 4075
2019
Q1
$86K Buy
14
+2
+17% +$12.3K ﹤0.01% 3949
2018
Q4
$31K Sell
12
-1
-8% -$2.58K ﹤0.01% 4117
2018
Q3
$66K Hold
13
﹤0.01% 4092
2018
Q2
$39K Buy
13
+4
+44% +$12K ﹤0.01% 4154
2018
Q1
$46K Hold
9
﹤0.01% 4089
2017
Q4
$48K Buy
9
+1
+13% +$5.33K ﹤0.01% 4079
2017
Q3
$59K Hold
8
﹤0.01% 4040
2017
Q2
$94K Buy
8
+1
+14% +$11.8K ﹤0.01% 3989
2017
Q1
$126K Sell
7
-12
-63% -$216K ﹤0.01% 3907
2016
Q4
$339K Buy
19
+11
+138% +$196K ﹤0.01% 3622
2016
Q3
$170K Buy
8
+1
+14% +$21.3K ﹤0.01% 3781
2016
Q2
$104K Buy
7
+1
+17% +$14.9K ﹤0.01% 3884
2016
Q1
$91K Hold
6
﹤0.01% 3928
2015
Q4
$59K Hold
6
﹤0.01% 4030
2015
Q3
$62K Buy
6
+1
+20% +$10.3K ﹤0.01% 4024
2015
Q2
$116K Sell
5
-1
-17% -$23.2K ﹤0.01% 3925
2015
Q1
$151K Hold
6
﹤0.01% 3938
2014
Q4
$207K Hold
6
﹤0.01% 3806
2014
Q3
$196K Sell
6
-21
-78% -$686K ﹤0.01% 3841
2014
Q2
$753K Sell
27
-7
-21% -$195K ﹤0.01% 3495
2014
Q1
$1.01M Sell
34
-2
-6% -$59.4K ﹤0.01% 3396
2013
Q4
$1.26M Buy
36
+1
+3% +$34.9K ﹤0.01% 3328
2013
Q3
$834K Buy
35
+21
+150% +$500K ﹤0.01% 3372
2013
Q2
$622K Buy
+14
New +$622K ﹤0.01% 3412